A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Clinical trial NCT05747508 · UNKNOWN

Trial details

NCT number: NCT05747508
Sponsor: Bellerophon
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Fibrosis Pulmonary Hypertension

Start date: 2017-12-29
Primary completion: 2019-11-22
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.